GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Elixinol Wellness Ltd (FRA:E8M) » Definitions » EV-to-EBITDA

Elixinol Wellness (FRA:E8M) EV-to-EBITDA : -0.90 (As of Dec. 12, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Elixinol Wellness EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Elixinol Wellness's enterprise value is €3.26 Mil. Elixinol Wellness's EBITDA for the trailing twelve months (TTM) ended in Jun. 2024 was €-3.62 Mil. Therefore, Elixinol Wellness's EV-to-EBITDA for today is -0.90.

The historical rank and industry rank for Elixinol Wellness's EV-to-EBITDA or its related term are showing as below:

FRA:E8M' s EV-to-EBITDA Range Over the Past 10 Years
Min: -3545.9   Med: -0.41   Max: 0.53
Current: -0.91

During the past 6 years, the highest EV-to-EBITDA of Elixinol Wellness was 0.53. The lowest was -3545.90. And the median was -0.41.

FRA:E8M's EV-to-EBITDA is ranked worse than
100% of 718 companies
in the Drug Manufacturers industry
Industry Median: 14.19 vs FRA:E8M: -0.91

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-12-12), Elixinol Wellness's stock price is €0.019. Elixinol Wellness's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was €-0.039. Therefore, Elixinol Wellness's PE Ratio (TTM) for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).


Elixinol Wellness EV-to-EBITDA Historical Data

The historical data trend for Elixinol Wellness's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Elixinol Wellness EV-to-EBITDA Chart

Elixinol Wellness Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
Get a 7-Day Free Trial -0.87 -1.35 -0.91 -0.61 -1.19

Elixinol Wellness Semi-Annual Data
Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -0.61 - -1.19 -

Competitive Comparison of Elixinol Wellness's EV-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Elixinol Wellness's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Elixinol Wellness's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Elixinol Wellness's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Elixinol Wellness's EV-to-EBITDA falls into.



Elixinol Wellness EV-to-EBITDA Calculation

Elixinol Wellness's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=3.260/-3.621
=-0.90

Elixinol Wellness's current Enterprise Value is €3.26 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Elixinol Wellness's EBITDA for the trailing twelve months (TTM) ended in Jun. 2024 was €-3.62 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Elixinol Wellness  (FRA:E8M) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Elixinol Wellness's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.019/-0.039
=At Loss

Elixinol Wellness's share price for today is €0.019.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Elixinol Wellness's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was €-0.039.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).

Please read Which price ratio outperforms the enterprise multiple?


Elixinol Wellness EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Elixinol Wellness's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Elixinol Wellness Business Description

Traded in Other Exchanges
Address
680 George Street, Level 12, Sydney, NSW, AUS, 2000
Elixinol Wellness Ltd is engaged in the hemp industry, innovating, marketing, and selling hemp-derived nutraceutical, cosmetic, and food products. It operates in the three operating segments of the Americas, Australia, Rest of the World regions of which key revenue is derived from the Australia segment. The Australia segment includes the results from operations of Elixinol Wellness (Byron Bay) Pty Ltd and The Sustainable Nutrition Group Pty Ltd and its subsidiaries.

Elixinol Wellness Headlines

No Headlines